Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Multiplex PCR Assays Market Size Shifted, And What Is the Outlook Through 2034?

Over recent years, there has been a significant expansion in the multiplex pcr assays market. The market, currently valued at $1.51 billion in 2024, is expected to reach $1.72 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. This robust growth in the past years can be linked to several factors, including a higher occurrence rate of infectious diseases, more substantial government sponsorships, a surge in its incorporation in clinical diagnosis, an upswing in genetic testing and tailored healthcare, an enlarging user base in academic and research facilities, advancements in bioinformatics and data analysis methods, and growing healthcare spending.

How Much Will the Multiplex PCR Assays Market Be Worth in 2029?

In the forthcoming years, a swift growth is projected for the multiplex pcr assays market. The market is anticipated to escalate to $2.83 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.4%. Several factors can explain this predicted growth in the given period, such as the broadening of application domains, an escalating demand for point-of-care diagnostics, the rise of personalized medicine, elevated expenditure on research and development, an upward trend in health consciousness and proactive healthcare, a growing emphasis on precision medicine, and a surging need for rapid and trustworthy diagnostic assessments. Leading trends set to shape the forecast period include the integration of next-generation sequencing (NGS), companion diagnostics, the use of digital PCR technology, automation and high-throughput systems, point-of-care and portable devices, customization and multiplexing capacities, the enhancement of artificial intelligence and machine learning, improved data handling, and the integration of cloud solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

Which is the Largest Company in the Multiplex PCR Assays Market?

Major companies operating in the multiplex PCR assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

What Are the Main Market Drivers in the Multiplex PCR Assays Industry?

The surge in the need for diagnostic testing is anticipated to boost the expansion of the multiplex PCR assay market in the future. Diagnostic testing includes procedures or tests that ascertain the existence or nonexistence of a disease or condition in an individual. The escalating demand for diagnostic testing is influenced by the growth of chronic illnesses such as cancer and diabetes, demanding timely and precise diagnosis for effective treatment. Further, the emphasis on preventive healthcare motivates regular testing to identify potential problems at an early stage. Multiplex PCR assays facilitate the concurrent detection and study of multiple pathogens or genetic markers from a single specimen, intensifying the effectiveness and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS), a hospital and healthcare provider based in the U.K., reported that diagnostic activity surpassed pre-pandemic levels in 2023, witnessing a 21% rise in tests conducted in May 2024 as compared to the prior year. Furthermore, 2.4 million diagnostic tests were executed in May 2024. Consequently, the escalating demand for diagnostic testing will drive the expansion of the multiplex PCR assay market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp

How Is the Multiplex PCR Assays Market Segments Structured?

The multiplex pcr assays market covered in this report is segmented –

1) By Assay Type: Planar Assay, Bead Based Assay

2) By Product And Services: Consumables, Instruments, Software And Services

3) By Application: Disease Diagnosis, Research And Development, Other Applications

4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:

1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays

2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

What Strategic Trends Are Transforming the Multiplex PCR Assays Market?

Top-tier firms in the multiplex PCR assays market are streamlining their operations via automation. They are using leading-edge quantitative PCR (qPCR) systems for precise and adaptable nucleic acid quantification in advanced medical diagnostics and public health. These innovative qPCR systems provide high-capacity, accurate, and concurrent detection of multiple targets, thereby enhancing the precision and efficiency of diagnosis. For example, in November 2023, Roche Diagnostics Corporation, a diagnostic system solutions provider from Switzerland, unveiled the LightCycler PRO System. This latest qPCR platform presents high-capacity, accurate, and simultaneous detection of numerous targets. With improved temperature uniformity, sophisticated software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, it augments accuracy and efficiency in diagnosis. This system underlines the implementation of automation in the multiplex PCR assays market, thereby propelling advancements in medical diagnostics and public health.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

Which Global Regions Offer the Highest Growth in the Multiplex PCR Assays Market?

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18681

This Report Delivers Insight On:

1. How big is the multiplex pcr assays market, and how is it changing globally?

2. Who are the major companies in the multiplex pcr assays market, and how are they performing?

3. What are the key opportunities and risks in the multiplex pcr assays market right now?

4. Which products or customer segments are growing the most in the multiplex pcr assays market?

5. What factors are helping or slowing down the growth of the multiplex pcr assays market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model